Tag: autoimmune disease
Cradle signs a drug discovery deal with Hansa Biopharma
The Swedish drugmaker picked an AI protein-design platform over rivals to engineer its next autoimmune therapies.
Boehringer Ingelheim taps Immunai AI platform in $15 million deal
Boehringer Ingelheim pays $15M for Immunai's AI platform to find shared T-cell targets across cancer and autoimmune disease.